Medical Condition News

RSS

New Gamma Knife stereotactic radiosurgery reduces severe facial pain caused by nerve disorder

Research by Beaumont Health System radiation oncologists and neurosurgeons found that symptoms of trigeminal neuralgia, or TN, a nerve disorder causing severe facial pain, were reduced in those treated with Gamma Knife stereotactic radiosurgery.

27 Feb 2014

Handgrip strength may be linked to cancer survival rates, shows research

New acquaintances are often judged by their handshake. Research has now recognized the simple squeeze as an important diagnostic tool in assessing strength and quality of life among critical care patients.

27 Feb 2014

Depression and self-awareness affect subjective reports of memory and satisfaction with life

Kessler Foundation researchers have found that among individuals with TBI, depression and self-awareness affect subjective reports of memory, quality of life (QOL), and satisfaction with life.

26 Feb 2014

Study demonstrates impact of vitamin D on social behavior linked with ASD

A new study by Rhonda Patrick, PhD and Bruce Ames, PhD of Children's Hospital Oakland Research Institute (CHORI) demonstrates the impact that Vitamin D may have on social behavior associated with Autism Spectrum Disorder (ASD).

26 Feb 2014

CCNAP highlights psychological issues related to cardiac diseases

The congress will be held 4-5 April in Stavanger, Norway, at the Stavanger Forum.

26 Feb 2014

New scientific blood analysis predicts short-term mortality in humans

The general state of a person's metabolism can be diversely illustrated with a new scientific blood analysis. With the aid of the analysis biomarkers predicting short-term mortality have now been discovered

26 Feb 2014

Therapeutic hypothermia may not be effective in all patients who suffered heart attack, says study

Whole body cooling in comatose patients who have suffered a heart attack can limit the damage to brain tissue caused by the restoration of blood flow and oxygen.

26 Feb 2014

Study explores influence of reproductive, hormonal factors on overall survival of women with NSCLC

Survival among people with lung cancer has been better for women than men, and the findings of a recent study indicate that female hormones may be a factor in this difference.

26 Feb 2014

Cognitive decline in obese diabetic mice can be reversed with regular exercise, surgical removal of belly fat

Cognitive decline that often accompanies obesity and diabetes can be reversed with regular exercise or surgical removal of belly fat, scientists report.

26 Feb 2014

Anika Therapeutics receives marketing approval from FDA for MONOVISC injection

Anika Therapeutics, Inc. today announced it has received marketing approval for MONOVISC from the U.S. Food and Drug Administration. MONOVISC is a single injection supplement to synovial fluid of the osteoarthritic joint, used to treat pain and improve joint mobility in patients suffering from osteoarthritis (OA) of the knee.

26 Feb 2014

Report calls for better palliative and EOL care for patients that relapse following transplant

Haematological disorders of the blood and bone marrow, such as leukaemia, are commonly treated with a bone marrow transplant. However relapse is common and often leads to treatment failure and death.

26 Feb 2014

Study highlights the importance of personalized medicine for treating cancer

If a driver is traveling to New York City, I-95 might be their route of choice. But they could also take I-78, I-87 or any number of alternate routes. Most cancers begin similarly, with many possible routes to the same disease. A new study found evidence that assessing the route to cancer on a case-by-case basis might make more sense than basing a patient's cancer treatment on commonly disrupted genes and pathways.

26 Feb 2014

FDA approves KALYDECO for people with cystic fibrosis

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) for KALYDECOTM (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have one of eight additional mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. KALYDECO was first approved in January 2012 for people with CF ages 6 and older who have at least one copy of the G551D mutation.

26 Feb 2014

Second common type of breast cancer appears to be good candidate for personalized treatment approach

The second-most common type of breast cancer is a very different disease than the most common and appears to be a good candidate for a personalized approach to treatment, according to a multidisciplinary team led by University of Pittsburgh Cancer Institute (UPCI) scientists.

26 Feb 2014

Regeneron receives FDA acceptance for EYLEA injection for treatment of macular edema

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for standard review the Company's supplemental Biologics License Application (sBLA) for EYLEA® (aflibercept) Injection for the treatment of Macular Edema following Branch Retinal Vein Occlusion (BRVO).

26 Feb 2014

K-PAX Pharmaceuticals works with Stanford University to identify effective treatment for chronic fatigue

K-PAX Pharmaceuticals is working with Stanford University and several other leading research institutions to perform a Phase II double-blind, placebo-controlled trial to evaluate the safety and efficacy of a currently available FDA-approved medication concurrently administered with a novel mitochondrial support product in order to identify a safe and effective treatment for the chronic fatigue and decreased alertness (i.e. brain fog) that commonly afflicts people with CFS.

26 Feb 2014

Robotic-assisted radical prostatectomy shows better outcomes in cancer removal

An observational study from UCLA's Jonsson Comprehensive Cancer comparing robotic-assisted prostate surgery to open surgery for prostate cancer found that patients who had robotic surgery had fewer instances of cancer cells at the edge of the surgical specimen, or fewer positive margins, and less need of additional cancer treatments, such as hormone therapy or radiation, than patients who had open surgery.

26 Feb 2014

New diagnosis guidelines for ASD may reduce total number of people being diagnosed by one third

New diagnosis guidelines for autism spectrum disorder (ASD) issued by the American Psychiatric Association (APA) may reduce by almost one third the total number of people being diagnosed, according to new research from Columbia University School of Nursing published in the Journal of Autism and Developmental Disorders.

26 Feb 2014

New way to potentially block chronic pain affecting osteoarthritis sufferers

Researchers from the Arthritis Research UK Pain Centre at The University of Nottingham have discovered a new way to potentially block the chronic and often debilitating pain affecting osteoarthritis sufferers.

26 Feb 2014

Scales of zebrafish suitable for identifying new drugs for treating bone diseases

The scales of the zebrafish are very suitable for identifying potential new drugs for treating bone diseases. This is good news because it means fewer mice and rats will be needed for that work.

26 Feb 2014

Medical Condition News

New Gamma Knife stereotactic radiosurgery reduces severe facial pain caused by nerve disorder

Handgrip strength may be linked to cancer survival rates, shows research

Depression and self-awareness affect subjective reports of memory and satisfaction with life

Study demonstrates impact of vitamin D on social behavior linked with ASD

CCNAP highlights psychological issues related to cardiac diseases

New scientific blood analysis predicts short-term mortality in humans

Therapeutic hypothermia may not be effective in all patients who suffered heart attack, says study

Study explores influence of reproductive, hormonal factors on overall survival of women with NSCLC

Cognitive decline in obese diabetic mice can be reversed with regular exercise, surgical removal of belly fat

Anika Therapeutics receives marketing approval from FDA for MONOVISC injection

Report calls for better palliative and EOL care for patients that relapse following transplant

Study highlights the importance of personalized medicine for treating cancer

FDA approves KALYDECO for people with cystic fibrosis

Second common type of breast cancer appears to be good candidate for personalized treatment approach

Regeneron receives FDA acceptance for EYLEA injection for treatment of macular edema

K-PAX Pharmaceuticals works with Stanford University to identify effective treatment for chronic fatigue

Robotic-assisted radical prostatectomy shows better outcomes in cancer removal

New diagnosis guidelines for ASD may reduce total number of people being diagnosed by one third

New way to potentially block chronic pain affecting osteoarthritis sufferers

Scales of zebrafish suitable for identifying new drugs for treating bone diseases

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Latest News